CVR: 29428441
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees. In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity amounted to DKK -10,313,267.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at arbejde med virksomhed indenfor genetisk screening, dna-undersøgelser samt hermed beslægtet virksomhed
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 4 mio. | -1.6 mio. | 2.9 mio. | -10.3 mio. | 12 | |
| 2024 | 3.4 mio. | -11.1 mio. | 3.6 mio. | -8.7 mio. | 14 | |
| 2023 | 3.2 mio. | -3.1 mio. | 15 mio. | 2.4 mio. | 15 | |
| 2022 | 5.5 mio. | -2.3 mio. | 12.3 mio. | -14.5 mio. | 14 | |
| 2021 | 20.3 mio. | 12.3 mio. | 18.4 mio. | -12.2 mio. | 13 | |
| 2020 | 12.4 mio. | 5.9 mio. | 12.3 mio. | -24.5 mio. | 7 | |
| 2019 | 2.8 mio. | -1.5 mio. | 4 mio. | -30.4 mio. | 7 | |
| 2018 | 907 t. | -3.7 mio. | 5.3 mio. | -28.9 mio. | 7 | |
| 2017 | 718 t. | -3 mio. | 6.3 mio. | -25.2 mio. | 6 | |
| 2016 | 440 t. | -2.7 mio. | 2.7 mio. | -22.3 mio. | - | |
| 2015 | 157 t. | -3.4 mio. | 2.3 mio. | -19.6 mio. | - | |
| 2014 | -186 t. | -3.4 mio. | 3 mio. | -16.2 mio. | - | |
| 2013 | -786 t. | -5.9 mio. | 4.5 mio. | -12.8 mio. | - | |
| 2012 | -538 t. | -2.1 mio. | 5.4 mio. | -7 mio. | - |
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 1.506 companies in Anden teknisk rådgivning
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
AMPLEXA GENETICS A/S has published its annual report for 2025. Gross profit came to DKK 4,009,035, and the net result was DKK -1,583,233.
Contact info changed: new phone: 66116628, new email: [email protected] (April 11, 2026).
Contact info changed: new phone: 66116628, new email: [email protected] (April 10, 2026).
As of April 10, 2026, Magnus Herdalur has joined the board of directors of AMPLEXA GENETICS A/S.
As of April 10, 2026, Johan Jan Albinus Dahl has left the board of directors of AMPLEXA GENETICS A/S.
AMPLEXA GENETICS A/S has published its annual report for 2024. Gross profit came to DKK 3,398,662, and the net result was DKK -11,108,344.
As of December 31, 2024, SCIENT. INVEST ApS is registered as an owner of AMPLEXA GENETICS A/S with an ownership share of 33%.
As of December 31, 2024, is registered as an owner of AMPLEXA GENETICS A/S with an ownership share of 33%.
AMPLEXA GENETICS A/S has published its annual report for 2023. Gross profit came to DKK 3,224,941, and the net result was DKK -3,131,078.
AMPLEXA GENETICS A/S has published its annual report for 2022. Gross profit came to DKK 5,494,691, and the net result was DKK -2,282,128.
As of April 17, 2023, is registered as an owner of AMPLEXA GENETICS A/S with an ownership share of 25%.
As of March 16, 2023, Ulf Bech Christensen has joined the board of directors of AMPLEXA GENETICS A/S.
As of March 16, 2023, Nils Christian Jensen has left the board of directors of AMPLEXA GENETICS A/S.
As of March 16, 2023, Leif Abrahamsen has left the board of directors of AMPLEXA GENETICS A/S.
As of March 16, 2023, Charles Steven Glavas has left the board of directors of AMPLEXA GENETICS A/S.
AMPLEXA GENETICS A/S has published its annual report for 2021. Gross profit came to DKK 20,278,070, and the net result was DKK 12,328,350.
AMPLEXA GENETICS A/S has published its annual report for 2020. Gross profit came to DKK 12,423,888, and the net result was DKK 5,872,852.
As of April 1, 2021, Hans Atli Eli Albinus Dahl is registered as adm. dir. of AMPLEXA GENETICS A/S.
As of March 31, 2021, Helle Hjalgrim has stepped down as adm. dir. of AMPLEXA GENETICS A/S.
AMPLEXA GENETICS A/S has published its annual report for 2019. Gross profit came to DKK 2,830,722, and the net result was DKK -1,500,826.
AMPLEXA GENETICS A/S has published its annual report for 2018. Gross profit came to DKK 906,955, and the net result was DKK -3,661,357.
AMPLEXA GENETICS A/S has published its annual report for 2017. Gross profit came to DKK 718,089, and the net result was DKK -2,969,411.
As of April 24, 2018, Leif Abrahamsen has joined the board of directors of AMPLEXA GENETICS A/S.
As of April 24, 2018, Charles Steven Glavas has joined the board of directors of AMPLEXA GENETICS A/S.
As of April 24, 2018, Pál Magni Weihe has left the board of directors of AMPLEXA GENETICS A/S.
As of February 1, 2018, Helle Hjalgrim is registered as adm. dir. of AMPLEXA GENETICS A/S.
As of February 1, 2018, Hans Atli Eli Albinus Dahl has stepped down as adm. dir. of AMPLEXA GENETICS A/S.
AMPLEXA GENETICS A/S has published its annual report for 2016. Gross profit came to DKK 439,860, and the net result was DKK -2,695,686.
AMPLEXA GENETICS A/S has published its annual report for 2015. Gross profit came to DKK 157,496, and the net result was DKK -3,373,569.
As of November 2, 2015, Johan Jan Albinus Dahl has joined the board of directors of AMPLEXA GENETICS A/S.
As of September 30, 2015, Jørn Kildegaard Andersen has left the board of directors of AMPLEXA GENETICS A/S.
As of May 31, 2015, Leif Mosekilde has left the board of directors of AMPLEXA GENETICS A/S.
AMPLEXA GENETICS A/S has published its annual report for 2014. Gross profit came to DKK -185,712, and the net result was DKK -3,386,966.
AMPLEXA GENETICS A/S has published its annual report for 2013. Gross profit came to DKK -785,662, and the net result was DKK -5,860,653.
As of October 1, 2013, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of AMPLEXA GENETICS A/S.
As of October 1, 2013, RATH & KNUDSEN STATSAUTORISEREDE REVISORER AKTIESELSKAB has stepped down as auditor of AMPLEXA GENETICS A/S.
As of October 1, 2013, Jørn Kildegaard Andersen has joined the board of directors of AMPLEXA GENETICS A/S.
As of October 1, 2013, Nils Christian Jensen has joined the board of directors of AMPLEXA GENETICS A/S.
As of October 1, 2013, Leif Mosekilde has joined the board of directors of AMPLEXA GENETICS A/S.
AMPLEXA GENETICS A/S has published its annual report for 2012. Gross profit came to DKK -538,092, and the net result was DKK -2,070,084.
As of June 17, 2011, RATH & KNUDSEN STATSAUTORISEREDE REVISORER AKTIESELSKAB has been appointed auditor of AMPLEXA GENETICS A/S.
As of June 17, 2011, Revisionsfirmaet Rath & Knudsen has stepped down as auditor of AMPLEXA GENETICS A/S.
As of April 1, 2011, Hans Atli Eli Albinus Dahl is registered as adm. dir. of AMPLEXA GENETICS A/S.
As of March 31, 2011, Klaus Brusgaard has stepped down as director of AMPLEXA GENETICS A/S.
As of January 25, 2011, Eydfinn Reydberg has joined the board of directors of AMPLEXA GENETICS A/S.
As of December 1, 2010, Marita Rasmussen has left the board of directors of AMPLEXA GENETICS A/S.
As of December 1, 2009, Pál Magni Weihe has joined the board of directors of AMPLEXA GENETICS A/S.
As of December 1, 2009, Andras Splidt has left the board of directors of AMPLEXA GENETICS A/S.
As of December 15, 2008, Andras Splidt has joined the board of directors of AMPLEXA GENETICS A/S.
As of September 26, 2008, Johan Dahl has left the board of directors of AMPLEXA GENETICS A/S.
As of March 25, 2006, Revisionsfirmaet Rath & Knudsen has been appointed auditor of AMPLEXA GENETICS A/S.
As of March 25, 2006, Johan Dahl has joined the board of directors of AMPLEXA GENETICS A/S.
As of March 25, 2006, Marita Rasmussen has joined the board of directors of AMPLEXA GENETICS A/S.
As of March 25, 2006, Klaus Brusgaard is registered as director of AMPLEXA GENETICS A/S.
AMPLEXA GENETICS A/S was founded on March 25, 2006.
Companies in the same industry and area
CVR 41424370
CVR 15552840
CVR 38381733
CVR 43607421
CVR 46161408